Stock 688621 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Equities

688621

CNE100005139

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 07/05/2024 BST 		5-day change 1st Jan Change
57.72 CNY -1.05% Intraday chart for Beijing Sun-Novo Pharmaceutical Research Co., Ltd. +2.43% -17.25%
04-25 Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-26 Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Chart calendar Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

f5d90c9b2.aAR1syJy54LDM4KfHC11nsEUvMopRevCU6smJalRwK8.GXUFgFgYps6MaeHJVWwa0555-K5ic9zvNcNWevoCtvkMQ0HLVRWCsrEK9Q~93230815696dbfa7ba0791342d60282f

Upcoming events on Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

15/08/2024 Q2 2024 Earnings Release (Projected)
22/10/2024 Q3 2024 Earnings Release (Projected)
02/03/2025 Q4 2024 Earnings Release (Projected)
24/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

25/04/2024 Q4 2023 Earnings Release
24/04/2024 Q1 2024 Earnings Release
30/10/2023 Q3 2023 Earnings Release
28/08/2023 Q2 2023 Earnings Release
28/04/2023 Q1 2023 Earnings Release
10/03/2023 Q4 2022 Earnings Release
24/10/2022 Q3 2022 Earnings Release
09/08/2022 Interim 2022 Earnings Release
28/04/2022 Q1 2022 Earnings Release
27/02/2022 FY 2021 Earnings Release
27/10/2021 Q3 2021 Earnings Release

Past dividends on Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

11/05/2023 Annual 0.6 CNY
14/04/2022 Annual 0.265 CNY

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million CNY		Released
Forecast
Spread 		347


0,00


677
689
-1.8%		954
927
2.86%
1 260

EBITDA
Million CNY		Released
Forecast
Spread 		0,00


0,00


200
204
-1.8%		237
290
-18.49%
355

EBIT
Million CNY		Released
Forecast
Spread 		0,00


0,00


169
168
0.76%		202
244
-17.17%
317

Earnings before Tax (EBT)
Million CNY		Released
Forecast
Spread 		0,00


0,00


169
175
-3.35%		201
247
-18.48%
307

Net income
Million CNY		Released
Forecast
Spread 		72,5


106


156
152
2.6%		194
220
-11.93%
277

EPS
CNY		Released
Forecast
Spread 		0,00


1,08


1,39
1,36
2.63%		1,73
2,23
-22.42%
2,48

Announcement Date31/05/2127/02/2209/02/2326/02/24-

Upcoming sector events for Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

08/05/2024 POLARIS GROUP: Q1 2024 Earnings Release (Projected)
08/05/2024 VORONOI, INC.: Q1 2024 Earnings Release (Projected)
08/05/2024 OMNIAB, INC.: Q1 2024 Earnings Release
08/05/2024 EDGEWISE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
08/05/2024 PHATHOM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
08/05/2024 GINKGO BIOWORKS HOLDINGS, INC.: Q1 2024 Earnings Release
08/05/2024 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
08/05/2024 COMPASS PATHWAYS PLC: Q1 2024 Earnings Release (Projected)
08/05/2024 NUVALENT, INC.: Q1 2024 Earnings Release (Projected)
08/05/2024 AMICUS THERAPEUTICS, INC.: Q1 2024 Earnings Release
More events

Past sector events for Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Today 21:05 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release
Today 21:05 ACADIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release
Today 21:01 ARCTURUS THERAPEUTICS HOLDINGS INC.: Q1 2024 Earnings Release
Today MIND MEDICINE (MINDMED) INC.: Q1 2024 Earnings Release
Today BELITE BIO, INC: Q1 2024 Earnings Release (Projected)
Today FORMYCON AG: Q1 2024 Earnings Release
Today AN2 THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today CELLTRION, INC.: Q1 2024 Earnings Release (Projected)
Today TANGO THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today VIRIDIAN THERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688621 Stock
  4. Calendar Beijing Sun-Novo Pharmaceutical Research Co., Ltd.